NATIONAL BANK OF CANADA /FI/ - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$187
-4.6%
3400.0%0.00%
Q2 2023$196
-17.6%
3400.0%0.00%
Q1 2023$238
-68.9%
3400.0%0.00%
Q4 2022$765
-23.5%
3400.0%0.00%
Q3 2022$1,0000.0%3400.0%0.00%
Q2 2022$1,000
-50.0%
3400.0%0.00%
Q1 2022$2,000
-60.0%
3400.0%0.00%
Q4 2021$5,0003400.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders